Christine Do Cao

Lille, 59037, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.

Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.

Journal: Journal of visceral surgery

Published: August 11, 2026

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Journal: Communications medicine

Published: February 23, 2026

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 28, 2025

Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network.

Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network.

Journal: Endocrine pathology

Published: November 17, 2025

Neuroendocrine tumors and pregnancy: the French PregNET study.

Neuroendocrine tumors and pregnancy: the French PregNET study.

Journal: European journal of endocrinology

Published: November 13, 2025

Neuroendocrine Tumors and Pregnancy: The French PregNET Study.

Neuroendocrine Tumors and Pregnancy: The French PregNET Study.

Journal: European journal of endocrinology

Published: November 13, 2025

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.

Journal: ESMO open

Published: September 16, 2025

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

Journal: Annales d'endocrinologie

Published: September 01, 2025

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 13, 2025

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 22, 2025

ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer management.

ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer management.

Journal: Annales d'endocrinologie

Published: April 11, 2025

ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer.

ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 07, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026